{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ADIL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T02:28:34.442Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":984,"canonical_name":"ADIAL PHARMACEUTICALS, INC.","cik":"0001513525","uei":null,"lei":null,"duns":null,"ticker":"ADIL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":40},"count":40,"timeline":[{"ts":"2026-10-05","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — ADIAL PHARMACEUTICALS, INC. — 2026-10-05","url_slug":"/sec/cik-0001513525/defa14a/0001213900-26-106577","accession_number":"0001213900-26-106577","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-10-02","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-106395","accession_number":"0001213900-26-106395","importance":35},{"ts":"2026-09-21","kind":"sec.filing","form_type":"4","title":"4 — ADIAL PHARMACEUTICALS, INC. — 2026-09-21","url_slug":"/sec/cik-0001513525/4/0001213900-26-101883","accession_number":"0001213900-26-101883","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-09-18","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-101434","accession_number":"0001213900-26-101434","importance":35},{"ts":"2026-09-18","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — ADIAL PHARMACEUTICALS, INC. — 2026-09-18","url_slug":"/sec/cik-0001513525/defa14a/0001213900-26-101500","accession_number":"0001213900-26-101500","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-09-16","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-100574","accession_number":"0001213900-26-100574","importance":35},{"ts":"2026-09-16","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — ADIAL PHARMACEUTICALS, INC. — 2026-09-16","url_slug":"/sec/cik-0001513525/defa14a/0001213900-26-100607","accession_number":"0001213900-26-100607","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"S-3","title":"S-3 — ADIAL PHARMACEUTICALS, INC. — 2026-08-28","url_slug":"/sec/cik-0001513525/s-3/0001213900-26-095122","accession_number":"0001213900-26-095122","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"S-8","title":"S-8 — ADIAL PHARMACEUTICALS, INC. — 2026-08-28","url_slug":"/sec/cik-0001513525/s-8/0001213900-26-095119","accession_number":"0001213900-26-095119","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-08-25","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-093544","accession_number":"0001213900-26-093544","importance":35},{"ts":"2026-08-24","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — ADIAL PHARMACEUTICALS, INC. — 2026-08-24","url_slug":"/sec/cik-0001513525/def-14a/0001213900-26-093019","accession_number":"0001213900-26-093019","importance":40},{"ts":"2026-08-24","kind":"sec.filing","form_type":"ARS","title":"ARS — ADIAL PHARMACEUTICALS, INC. — 2026-08-24","url_slug":"/sec/cik-0001513525/ars/0001213900-26-093022","accession_number":"0001213900-26-093022","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-08-21","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-092690","accession_number":"0001213900-26-092690","importance":35},{"ts":"2026-08-17","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-08-17","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-090482","accession_number":"0001213900-26-090482","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ADIAL PHARMACEUTICALS, INC. — 2026-08-14","url_slug":"/sec/cik-0001513525/10-q/0001213900-26-090051","accession_number":"0001213900-26-090051","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-08-13","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-089270","accession_number":"0001213900-26-089270","importance":35},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — ADIAL PHARMACEUTICALS, INC. — 2026-08-11","url_slug":"/sec/cik-0001513525/8-k-a/0001213900-26-087439","accession_number":"0001213900-26-087439","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — ADIAL PHARMACEUTICALS, INC. — 2026-08-11","url_slug":"/sec/cik-0001513525/pre-14a/0001213900-26-087445","accession_number":"0001213900-26-087445","importance":30},{"ts":"2026-07-16","kind":"sec.insider.p","reporter":"Coastlands Capital LP","title":"","shares":1233,"price_per_share":2.75,"usd_value":3391,"security_title":"Common Stock","importance":50.00339075},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — ADIAL PHARMACEUTICALS, INC. — 2026-07-16","url_slug":"/sec/cik-0001513525/4/0001104659-26-084300","accession_number":"0001104659-26-084300","importance":30},{"ts":"2026-07-14","kind":"sec.insider.p","reporter":"Coastlands Capital LP","title":"","shares":2000,"price_per_share":2.65,"usd_value":5300,"security_title":"Common Stock","importance":50.0053},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — ADIAL PHARMACEUTICALS, INC. — 2026-07-13","url_slug":"/sec/cik-0001513525/4/0001104659-26-082972","accession_number":"0001104659-26-082972","importance":30},{"ts":"2026-07-10","kind":"sec.insider.p","reporter":"Coastlands Capital LP","title":"","shares":1700,"price_per_share":2.7,"usd_value":4590,"security_title":"Common Stock","importance":50.00459},{"ts":"2026-07-09","kind":"sec.insider.p","reporter":"Coastlands Capital LP","title":"","shares":10053,"price_per_share":2.79,"usd_value":28048,"security_title":"Common Stock","importance":50.02804787},{"ts":"2026-06-29","kind":"sec.insider.p","reporter":"Coastlands Capital LP","title":"","shares":25000,"price_per_share":2.6,"usd_value":65000,"security_title":"Common Stock","importance":50.065},{"ts":"2026-06-29","kind":"sec.filing","form_type":"3","title":"3 — ADIAL PHARMACEUTICALS, INC. — 2026-06-29","url_slug":"/sec/cik-0001513525/3/0001104659-26-078710","accession_number":"0001104659-26-078710","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ADIAL PHARMACEUTICALS, INC. — 2026-06-24","url_slug":"/sec/cik-0001513525/schedule-13g/0001104659-26-077127","accession_number":"0001104659-26-077127","importance":55},{"ts":"2026-06-16","kind":"sec.filing","form_type":"3","title":"3 — ADIAL PHARMACEUTICALS, INC. — 2026-06-16","url_slug":"/sec/cik-0001513525/3/0001213900-26-069015","accession_number":"0001213900-26-069015","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"3","title":"3 — ADIAL PHARMACEUTICALS, INC. — 2026-06-16","url_slug":"/sec/cik-0001513525/3/0001213900-26-069035","accession_number":"0001213900-26-069035","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — ADIAL PHARMACEUTICALS, INC. — 2026-06-16","url_slug":"/sec/cik-0001513525/4/0001213900-26-069021","accession_number":"0001213900-26-069021","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — ADIAL PHARMACEUTICALS, INC. — 2026-06-16","url_slug":"/sec/cik-0001513525/4/0001213900-26-069037","accession_number":"0001213900-26-069037","importance":30},{"ts":"2026-06-12","kind":"sec.insider.a","reporter":"Davidson Matt","title":"Chief Development Officer","shares":232417,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-06-11","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-067711","accession_number":"0001213900-26-067711","importance":35},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Davidson Matt","title":"Chief Development Officer","shares":61647,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Davidson Matt","title":"Chief Development Officer","shares":3427,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Davidson Matt","title":"Chief Development Officer","shares":1822.13,"price_per_share":null,"usd_value":0,"security_title":"Series A Preferred Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Davidson Matt","title":"Chief Development Officer","shares":101.298,"price_per_share":null,"usd_value":0,"security_title":"Series A Preferred Stock","importance":15},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ADIAL PHARMACEUTICALS, INC. — 2026-05-15","url_slug":"/sec/cik-0001513525/schedule-13g-a/0001172661-26-002114","accession_number":"0001172661-26-002114","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"8-K","title":"8-K — ADIAL PHARMACEUTICALS, INC. — 2026-05-11","url_slug":"/sec/cik-0001513525/8-k/0001213900-26-054219","accession_number":"0001213900-26-054219","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ADIAL PHARMACEUTICALS, INC. — 2026-05-08","url_slug":"/sec/cik-0001513525/10-q/0001213900-26-053907","accession_number":"0001213900-26-053907","importance":45}]}